Show simple item record

dc.contributor.authorReyad, Ayman Antoun
dc.contributor.authorGirgis, Eriny
dc.contributor.authorMishriky, Raafat
dc.date.accessioned2019-04-05T09:57:00Z
dc.date.available2019-04-05T09:57:00Z
dc.date.issued2019-03-28
dc.identifier.citationReyad, A. A., Girgis, E. and Mishriky, R. (2019) Rabbit syndrome: update on aetiology and management for pharmacists, psychiatrists and dentists, International Journal of Current Medical And Pharmaceutical Research, 5(3), pp. 4103-4105.en
dc.identifier.issn2395-6429en
dc.identifier.doi10.24327/23956429.ijcmpr201902631en
dc.identifier.urihttp://hdl.handle.net/2436/622259
dc.description.abstractRabbit syndrome (RS) is an involuntary movement disorder, characterized by fast and fine movements of oral and masticatory muscles along the mouth vertical axis in the absence of tongue involvement. RS prevalence varies between 2.3% to 4.4% and could result from the administration of antipsychotics and antidepressants. In case of second generation antipsychotics, there is a reduced risk of RS compared with first generation antipsychotics with mainly isolated literature case reports especially with the use of risperidone as antipsychotic. RS affects only the buccal region, with the possible involvement of the basal ganglia, in particular the substantia nigra. The management of RS include reduction or change of the psychotropic treatment and use of anticholinergic medications such as trihexyphenidyl. Although RS is rare and easily treatable, it is essential that dentists and psychiatrists could distinguish this syndrome from other movement disorders such as tardive dyskinesia.en
dc.formatapplication/PDFen
dc.language.isoenen
dc.publisherJournalcmpren
dc.relation.urlhttp://journalcmpr.com/issues/rabbit-syndrome-update-aetiology-and-management-pharmacists-psychiatrists-and-dentistsen
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectantipsychoticsen
dc.subjectantidepressantsen
dc.subjectRabbit syndromeen
dc.subjectmovement disorderen
dc.subjectanticholinergicen
dc.titleRabbit syndrome: update on aetiology and management for pharmacists, psychiatrists and dentistsen
dc.typeJournal articleen
dc.identifier.journalInternational Journal of Current Medical and Pharmaceutical Researchen
dc.date.accepted2019-02-26
rioxxterms.funderUniversity of Wolverhamptonen
rioxxterms.identifier.projectOUW050419AARen
rioxxterms.versionVoRen
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0/en
rioxxterms.licenseref.startdate2019-04-05en
dc.source.volume5
dc.source.issue3
dc.source.beginpage4103
dc.source.endpage4105
refterms.dateFCD2019-04-05T09:56:11Z
refterms.versionFCDVoR
refterms.dateFOA2019-04-05T09:57:01Z


Files in this item

Thumbnail
Name:
Reyad_Rabbit_syndrome_2019.pdf
Size:
367.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States